Abstract
Exposure of rat brain Na+ + K+-ATPase (ATP phosphohydrolase E.C. 3.6.1.3) to concentrations of cassaine greater than 1 × 10-4 M resulted in a poorly reversible inhibition of this enzyme. Inhibition did not require the presence of ATP and developed rapidly, but the final amount of inhibition observed was independent of time. The amount of inhibition observed at a given concentration of cassaine was reduced by increasing the concentration of membranes in the system. The inhibition of Na+ + K+-ATPase activity was associated with equivalent inhibition of the phosphorylation and (3H)-ouabain binding reactions of this enzyme, while the uninhibited enzyme was apparently kinetically normal. Concentrations of cassaine which produced this stable inhibition of Na+ + K+-ATPase had no effect on the Mg2+-activated ATPase or the NADH cytochrome-c-reductase activities of crude rat brain microsomal preparations. Cassaine inhibited the cholinesterase activity of rat brain microsomes with a Ki of about 5 × 10-5 M, but this inhibition was fully reversible. The poorly reversible inhibitory actions of cassaine, thus, appeared specific for Na+ + K+-ATPase. Because this stable pattern of inhibition of the Na+ + K+-ATPase by cassaine required drug concentrations at least one hundred-fold greater than those which produce positive inotropic effects, it appears unlikely that this pattern of Na+ + K+-ATPase inhibition is involved in the cardiotonic actions of this drug.
Original language | English |
---|---|
Pages (from-to) | 59-68 |
Number of pages | 10 |
Journal | European Journal of Pharmacology |
Volume | 35 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1976 |
Bibliographical note
Funding Information:This work was supported by grants from the Michigan Heart Association, Grant HL 16055-01
Funding Information:
from the National Institutes of Health, and General Research Support Grant NIH RR 05623-04 from the College of Veterinary Medicine, Michigan State University, from the National Institutes of Health. The authors would like to thank Dr. Frank Welsch for helpful discussions and Mrs. Marilyn Turnbow for excellent technical assistance. Particular thanks are due to Doctor Schliep of E. Merck, Ltd. for making the original sample of cassaine available to us, and to Dr. O. Wasserman of Christian Albrechts University who provided us with a comparative sample of cassaine.
Keywords
- Cassaine
- Cholinesterase
- Erythrophleum alkaloids
- Na + K-ATPase
- Stable inhibition
ASJC Scopus subject areas
- Pharmacology